Proliferation-associated 2G4 pseudogene 2 (PA2G4P2)

PA2G4P2 (Proliferation-associated 2G4 pseudogene 2), also known as bA102J14.2 or PA2G4L5, is one of several processed pseudogenes derived from the PA2G4 (proliferation-associated protein 2G4) gene[4]. Pseudogenes are nonfunctional DNA segments that resemble original genes but do not produce active proteins[5]. While PA2G4 protein itself is implicated in cell growth regulation and cancer biology[1][7], the PA2G4P2 pseudogene is not known to have any therapeutic, enzymatic, or receptor function. Recent research on related pseudogenes (e.g., PA2G4P4) suggests some may act at the RNA level to influence cancer cell behavior, but there is no direct evidence for such a role for PA2G4P2. Overall, PA2G4P2 is not considered a conventional therapeutic target, and information beyond its genomic context is very limited. Summary: PA2G4P2 is a pseudogene with no established molecular or cellular function, no known disease-modifying role, and no drugs or biomarkers associated. It is not a conventional therapeutic target. Any information suggesting a therapeutic or mechanistic role is likely to be incorrect or speculative for this target.

Other names

bA102J14.2PA2G4L5